Fate Therapeutics makes appointment
This article was originally published in Scrip
Executive Summary
Fate Therapeutics (US/Canada) has named Dr Tom Novak vice-president of research and drug discovery. He was most recently senior director and head of discovery technologies at Roche, where he directed target discovery and assessment and formed and led Stem Cells for Research, a team designed to implement the use of stem cells as a drug discovery platform. Before that, he worked as senior research scientist and associate director at Wyeth.